3 recruiting, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 1 | Completed 1 |
Follow Enveda Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis ENV-294, Placebo - Atopic Dermatitis | Phase 2 | Recruiting | Enveda Therapeutics | 200 | 2026-06-29 | 2026-08-06 |
| ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults ENV-294, Placebo - Asthma | Phase 2 | Recruiting | Enveda Therapeutics | 50 | 2026-01-09 | 2026-09-24 |
| Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis ENV-294, Placebo - Atopic Dermatitis (AD) | Phase 2 | Recruiting | Enveda Therapeutics | 105 | 2025-12-22 | 2026-09-25 |
| Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis ENV-294 Capsule - Atopic Dermatitis (AD) | Phase 1 | Completed | Enveda Therapeutics | 9 | 2025-09-10 | 2026-04-01 |
Dermatitis, Atopic (3) · Asthma (1)
United States (4)